Lantheus Medical Imaging Overview
- Year Founded
-
1956
- Status
-
Public
- Employees
-
834
- Stock Symbol
-
LNTH
- Investments
-
7
- Share Price
-
$87.50
- (As of Friday Closing)
Lantheus Medical Imaging General Information
Description
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Contact Information
Website
www.lantheus.comCorporate Office
- 201 Burlington Road
- South Building
- Bedford, MA 01730
- United States
Corporate Office
- 201 Burlington Road
- South Building
- Bedford, MA 01730
- United States
Lantheus Medical Imaging Stock Performance
As of 08-Nov-2024, Lantheus Medical Imaging’s stock price is $87.50. Its current market cap is $6.08B with 69.5M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$87.50 | $88.31 | $50.20 - $126.89 | $6.08B | 69.5M | 794K | $6.21 |
Lantheus Medical Imaging Financials Summary
As of 30-Sep-2024, Lantheus Medical Imaging has a trailing 12-month revenue of $1.5B.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 7,481,176 | 4,247,892 | 3,433,207 | 2,041,203 |
Revenue | 1,496,799 | 1,296,429 | 935,061 | 425,208 |
EBITDA | 617,007 | 470,924 | 78,191 | (26,631) |
Net Income | 427,612 | 326,661 | 28,067 | (71,279) |
Total Assets | 2,049,630 | 1,651,149 | 1,321,258 | 863,784 |
Total Debt | 619,241 | 616,946 | 583,508 | 191,309 |
Lantheus Medical Imaging Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Lantheus Medical Imaging Comparisons
Industry
Financing
Details
Lantheus Medical Imaging Competitors (7)
One of Lantheus Medical Imaging’s 7 competitors is GE HealthCare Technologies, a Corporation company based in Chicago, IL.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
GE HealthCare Technologies | Corporation | Chicago, IL | ||||
Bruker | Formerly VC-backed | Billerica, MA | ||||
Bio-Rad Laboratories | Corporation | Hercules, CA | ||||
Guerbet Group | Corporation | Villepinte, France | ||||
Life Molecular Imaging | Corporate Backed or Acquired | Berlin, Germany |
Lantheus Medical Imaging Patents
Lantheus Medical Imaging Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2023217725-A1 | Gas nano/micro-bubble compositions and uses thereof | Pending | 09-Feb-2022 | ||
AU-2021322205-A1 | Methods and devices for preparation of ultrasound contrast agents | Pending | 04-Aug-2020 | ||
CA-3189851-A1 | Methods and devices for preparation of ultrasound contrast agents | Pending | 04-Aug-2020 | ||
EP-4192611-A1 | Methods and devices for preparation of ultrasound contrast agents | Pending | 04-Aug-2020 | ||
US-20230270412-A1 | Methods and devices for preparation of ultrasound contrast agents | Pending | 04-Aug-2020 | A61K49/223 |
Lantheus Medical Imaging Signals
Lantheus Medical Imaging Investments & Acquisitions (7)
Lantheus Medical Imaging’s most recent deal was a Corporate Asset Purchase with Lantheus Holdings (Global Rights to Life Molecular Imaging's RM2 Product) for . The deal was made on 28-Jun-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Lantheus Holdings (Global Rights to Life Molecular Imaging's RM2 Product) | 28-Jun-2024 | Corporate Asset Purchase | Buildings and Property | ||
Radiopharm Theranostics | 20-Jun-2024 | PIPE | Drug Discovery | ||
Meilleur Technologies | 18-Jun-2024 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
Cerveau Technologies | 06-Feb-2023 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
Ratio Therapeutics | 02-Feb-2023 | Early Stage VC | Biotechnology |
Lantheus Medical Imaging Subsidiaries (3)
Company Name | Industry | Location | Founded |
---|---|---|---|
Meilleur Technologies | Discovery Tools (Healthcare) | Dublin, OH | 2018 |
Cerveau Technologies | Discovery Tools (Healthcare) | Knoxville, TN | |
Lantheus Medical Imaging Retirement Savings Plan | Corporate Pension | North Billerica, MA |
Lantheus Medical Imaging ESG
Risk Overview
Risk Rating
Updated October, 15, 2024
33.06 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,035
Rank
Percentile
Pharmaceuticals
Industry
of 847
Rank
Percentile
Pharmaceuticals
Subindustry
of 423
Rank
Percentile
Lantheus Medical Imaging FAQs
-
When was Lantheus Medical Imaging founded?
Lantheus Medical Imaging was founded in 1956.
-
Where is Lantheus Medical Imaging headquartered?
Lantheus Medical Imaging is headquartered in Bedford, MA.
-
What is the size of Lantheus Medical Imaging?
Lantheus Medical Imaging has 834 total employees.
-
What industry is Lantheus Medical Imaging in?
Lantheus Medical Imaging’s primary industry is Other Devices and Supplies.
-
Is Lantheus Medical Imaging a private or public company?
Lantheus Medical Imaging is a Public company.
-
What is Lantheus Medical Imaging’s stock symbol?
The ticker symbol for Lantheus Medical Imaging is LNTH.
-
What is the current stock price of Lantheus Medical Imaging?
As of 08-Nov-2024 the stock price of Lantheus Medical Imaging is $87.50.
-
What is the current market cap of Lantheus Medical Imaging?
The current market capitalization of Lantheus Medical Imaging is $6.08B.
-
What is Lantheus Medical Imaging’s current revenue?
The trailing twelve month revenue for Lantheus Medical Imaging is $1.5B.
-
Who are Lantheus Medical Imaging’s competitors?
GE HealthCare Technologies, Bruker, Bio-Rad Laboratories, Guerbet Group, and Life Molecular Imaging are some of the 7 competitors of Lantheus Medical Imaging.
-
What is Lantheus Medical Imaging’s annual earnings per share (EPS)?
Lantheus Medical Imaging’s EPS for 12 months was $6.21.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »